dixit
★    

India,
2012-09-24 12:35
(5022 d 21:11 ago)

Posting: # 9242
Views: 3,738
 

 Fed study [Regulatives / Guidelines]

Dear All,

As per the EMEA requirement, fed study for a molecule is conducted only when SPC states that the pharmacokinetics is affected in fed conditions/ or by food. How to decide to conduct a fed study if the pharmacology states as below.

Mobiflex is rapidly and completely absorbed as unchanged drug. Concomitant food reduces the rate, but not the extent, of absorption of Mobiflex.
Regards,

DIXIT. :-)
ElMaestro
★★★

Denmark,
2012-09-24 12:49
(5022 d 20:57 ago)

@ dixit
Posting: # 9243
Views: 3,162
 

 Fed study

Hi dixit,

❝ Mobiflex is rapidly and completely absorbed as unchanged drug. Concomitant food reduces the rate, but not the extent, of absorption of Mobiflex.


I would assume that it essentially means the PK is affected by food (Cmax, but apparently not AUC). A food study, hence, is likely a necessity.

Pass or fail!
ElMaestro
The Outlaw Torn
★    

Europe,
2012-09-25 09:39
(5022 d 00:07 ago)

@ dixit
Posting: # 9246
Views: 3,139
 

 Fed study

Dear Dixit,

My take is a little different from ElMaestro.

The EMA guideline states the following:

"For products where the SmPC recommends intake of the reference medicinal product on an empty stomach or
irrespective of food intake, the bioequivalence study should hence be conducted under fasting conditions."


This is what the UK SPC for Mobiflex says:

A single daily dose of 20mg Mobiflex should be taken orally, at the same time each day. Mobiflex Tablets are for oral administration with water or other fluid.

There is no mention of food anywhere in the posology. Therefore, my opinion is that only a single fasting study is needed as "In general, a bioequivalence study should be conducted under fasting conditions as this is considered to be the most sensitive condition to detect a potential difference between formulations."

Anyone else see it this way (or not)?

Thanks,
Torn
Dr_Dan
★★  

Germany,
2012-09-25 13:11
(5021 d 20:35 ago)

@ The Outlaw Torn
Posting: # 9249
Views: 3,079
 

 Fed study

Dear Dixit,
dear Torn
The German PIL recommends the intake of Mobiflex Tablets two hours before or after food intake. Therefore I totally agree with Torn that only one BE study in the fasted state is needed even if the PK is significantly changed by food. As long as the SmPC does not expressly recommends to take a drug with food you have to perform a BE study in the fasted state. The objective of a bioequivalence study is, however, not the investigation of the pharmacokinetics of the drug entities itself, but the comparison of the pharmacokinetic profiles of galenic preparations and this should be conducted under a condition which is considered to be the most sensitive condition to detect a potential difference between formulations, i.e. fasted state.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan
sam
★    

India,
2012-09-29 08:21
(5018 d 01:25 ago)

(edited on 2012-09-29 12:32)
@ dixit
Posting: # 9278
Views: 3,039
 

 Fed study

Dear Dixit:

I am totally agreed with the recommendation of stated by Torn by EMEA for the fed study "For products where the SmPC recommends intake of the reference medicinal product on an empty stomach or irrespective of food intake, the bioequivalence study should hence be conducted under fasting conditions".
As per my experiences the fed study is not required for EMEA only when there is a statement in the Posology that the drug can be taken with or without food.
Since in the SPC of the Mobiflex this statement is not present and in the pharmacokinetics it has been clearly mentioned that the “Concomitant food reduces the rate, but not the extent, of absorption of Mobiflex”.
So as per my opinion you have to perform both the fasting and fed study.


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
Dr_Dan
★★  

Germany,
2012-10-01 12:52
(5015 d 20:54 ago)

@ sam
Posting: # 9286
Views: 2,993
 

 Fed study

Dear Sam

❝ I am totally agreed with the recommendation of stated by Torn by EMEA for the fed study "For products where the SmPC recommends intake of the reference medicinal product on an empty stomach or irrespective of food intake, the bioequivalence study should hence be conducted under fasting conditions".


❝ So as per my opinion you have to perform both the fasting and fed study.


IMHO there is a contradiction, right?
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
166 visitors (0 registered, 166 guests [including 37 identified bots]).
Forum time: 09:46 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5